Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Adds Tufts Heart Geneticist Ordovas to SAB; Diversa Brings on New SVP; Panvera Prez Leaves His Post

NEW YORK, Jan. 8-Tufts University geneticist Jose Ordovas has joined Perlegen Sciences' scientific advisory board, the company said in a statement today.

 

Ordovas, who is Professor of Nutrition and Genetics at Tufts, identifies and studies genes influencing blood lipids. His lab has been closely involved in the Framingham Heart Study, and is examining how genetic variation in different global population groups influences cardiovascular disease risk.

 

He will advise Perlegen in its efforts to understand the relationships between disease and genetic variation.

 


 

Diversa hired Edward Shonsey as senior vice president of internal development, the company said on Jan. 7.

 

Shonsey was previously with Syngenta, where he was involved in new product development and organizing R&D. He also has worked with Novartis and Pioneer Hi-Bred International.

           

Diversa is a San Diego-based company using genomics techniques to develop new agricultural, pharmaceutical and industrial products.

 


 

AnVil hired HIV expert Steven Henry as senior medical informaticist, the company said yesterday.

 

Henry has experience in bioinformatics, pharmacogenomics, genetic modeling, and direction of clinical trials. At GlaxoSmithKline, he was project leader for analysis of clinical pharmacology and genotype data, where he advised on the creation of genetic database systems in clinical research.

 

He was also medical/clinical project manager for FirstGenetic Trust.

 

AnVil is bioinformatics company based in Burlington, Mass.

 


 

Michael Wokasch left his post as president of Panvera to become COO of IMPAX, the Hayward, Calif.-based drug company said on Jan. 3.

 

At IMPAX, Wokasch will oversee manufacturing, packaging, engineering, materials management, warehousing, and human resources. Wokasch, 51, served on the board of IMPAX until his appointment as COO.

 

He will be replaced by Tom Schwei, general manager of the Vertex unit.

 

 


 

Bangalore-based bioinformatics company Strand Genomics appointed Todd Laird as senior vice president of business development.

 

Laird will be based in the company's San Francisco area office.

 

He was most recently VP of business development at life sciences middleware company GeneticXchange.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.